These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Letters to the Editor: Assessing the cost-effectiveness of allergen immunotherapy in allergic rhinitis. Incorvaia C; Makrì E; Ridolo E Am J Rhinol Allergy; 2014; 28(4):353. PubMed ID: 25197925 [No Abstract] [Full Text] [Related]
23. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis. Ciprandi G Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197 [TBL] [Abstract][Full Text] [Related]
24. [Allergic rhinitis in childhood--therapy and therapeutic success in a 5-year observation period]. Brunner FX Laryngol Rhinol Otol (Stuttg); 1986 May; 65(5):260-3. PubMed ID: 3736289 [TBL] [Abstract][Full Text] [Related]
25. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064 [TBL] [Abstract][Full Text] [Related]
27. Pediatric allergic rhinitis: current and future state of the art. Carr WW Allergy Asthma Proc; 2008; 29(1):14-23. PubMed ID: 18302833 [TBL] [Abstract][Full Text] [Related]
28. Immunological investigation and treatment of rhinitis and bronchial asthma. Sharp A Aust Fam Physician; 1985 Jun; 14(6):489-97. PubMed ID: 4026698 [No Abstract] [Full Text] [Related]
29. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual. Cox L; Wallace D Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043 [TBL] [Abstract][Full Text] [Related]
31. The health economics of allergen immunotherapy. Hankin CS; Cox L; Bronstone A Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823 [TBL] [Abstract][Full Text] [Related]
32. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951 [No Abstract] [Full Text] [Related]
33. Higher evidence for specific immunotherapy than reported in the ARIA update. Justicia JL; Mullol J J Allergy Clin Immunol; 2008 Feb; 121(2):536; author reply 536. PubMed ID: 18061656 [No Abstract] [Full Text] [Related]
34. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma. Bahceciler NN; Cobanoglu N Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312 [TBL] [Abstract][Full Text] [Related]
35. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059 [TBL] [Abstract][Full Text] [Related]